Compare SPPL & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPPL | SCNX |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | Singapore | United States |
| Employees | N/A | 19 |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.7M | 19.0M |
| IPO Year | 2022 | N/A |
| Metric | SPPL | SCNX |
|---|---|---|
| Price | $2.51 | $0.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | ★ 1.3M | 383.6K |
| Earning Date | 04-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1,097.38 |
| Revenue Next Year | N/A | $239.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $0.24 |
| 52 Week High | $7.00 | $2.60 |
| Indicator | SPPL | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 64.13 | 52.39 |
| Support Level | $2.51 | $0.38 |
| Resistance Level | $3.63 | $0.47 |
| Average True Range (ATR) | 0.14 | 0.03 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 95.45 | 61.65 |
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software (Facilities management software). The majority of its revenue is generated from the Robots segment. The company has expanded its operations into Australia /New Zealand and may also enter or expand in other geographic markets such as Canada, Hong Kong, Japan, the Middle East, the United Kingdom, Europe and the United States.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.